Invention Grant
- Patent Title: TGR5 modulators and methods of use thereof
-
Application No.: US13871492Application Date: 2013-04-26
-
Publication No.: US09650409B2Publication Date: 2017-05-16
- Inventor: Roberto Pellicciari
- Applicant: Intercept Pharmaceuticals, Inc.
- Applicant Address: US NY New York
- Assignee: Intercept Pharmaceuticals, Inc.
- Current Assignee: Intercept Pharmaceuticals, Inc.
- Current Assignee Address: US NY New York
- Agency: Cooley LLP
- Agent Ivor R. Elrifi; Heidi A. Erlacher
- Priority: EP08169462 20081119
- Main IPC: A61K31/575
- IPC: A61K31/575 ; C07J9/00 ; C07J31/00 ; C07J41/00
Abstract:
The invention relates to compounds of Formula A: or a salt, solvate, hydrate, or prodrug thereof. The compounds of Formula A are TGR5 modulators useful for the treatment of various diseases, including metabolic disease, inflammatory disease, liver disease, autoimmune disease, cardiac disease, kidney disease, cancer, and gastrointestinal disease.
Public/Granted literature
- US20140100209A1 TGR5 Modulators and Methods of Use Thereof Public/Granted day:2014-04-10
Information query
